Video Experimental Relacionado
Updated: Jul 23, 2026
09:29
Skeletal Muscle Gender Dimorphism from Proteomics
Published on: December 14, 2011
Identificación de las ligasas de ubiquitina requeridas para la atrofia del músculo esquelético
S C Bodine1, E Latres, S Baumhueter
1Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591-6707, USA.
Science (New York, N.Y.)
|October 27, 2001
Resumen
Los investigadores identificaron proteínas clave, el dedo anular muscular 1 (MuRF1) y la caja F de atrofia muscular (MAFbx), que impulsan la atrofia del músculo esquelético. Los ratones que carecían de estas proteínas mostraron resistencia al desgaste muscular, lo que sugiere que son posibles blancos de fármacos.
Área de la Ciencia:
- Biología molecular La biología molecular.
- Biología celular Biología celular.
- Fisiología Fisiología Fisiología.
Sus antecedentes:
- La atrofia del músculo esquelético, una disminución de la masa muscular, se produce debido a la reducción de la actividad o la carga.
- La identificación de los mecanismos moleculares subyacentes a la atrofia muscular es crucial para el desarrollo de estrategias terapéuticas.
Objetivo del estudio:
- Identificar nuevos mediadores moleculares responsables de la atrofia del músculo esquelético.
- Para investigar el papel de las ligasas específicas de la ubiquitina en el proceso de desgaste muscular.
Principales métodos:
- El perfil de transcripción se empleó en varios modelos de ratas de atrofia muscular.
- Se analizaron los patrones de expresión génica para identificar genes universalmente regulados.
- Los estudios funcionales involucraron la sobreexpresión de MAFbx en los miotubos y la deficiencia genética de MAFbx y MuRF1 en ratones.
Principales resultados:
- Un pequeño subconjunto de genes fue universalmente regulado al alza en todos los modelos de atrofia.
- Se identificaron dos ligasas clave de ubiquitina, el dedo del anillo muscular 1 (MuRF1) y la caja F de atrofia muscular (MAFbx).
- La sobreexpresión de MAFbx indujo atrofia en los miotubos, mientras que los ratones con deficiencia de MAFbx o MuRF1 fueron resistentes a la atrofia.
Conclusiones:
- MAFbx y MuRF1 son mediadores críticos de la atrofia del músculo esquelético.
- Estas ligasas de ubiquitina representan objetivos terapéuticos potenciales para combatir las enfermedades de desgaste muscular.
Palabras clave:
No programático No programático
Videos de Conceptos Relacionados
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
02:58Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...